Fuze Biotech, a company specializing in the development of sustainable antibacterial and fast-drying fabric and surface finishes, has announced the relocation of its headquarters to a larger facility in Salt Lake City, Utah. The move is aimed at meeting the exponential growth in demand for its gold-powered antibacterial solution and scaling up production to better serve its expanding roster of sustainability-focused partner brands in North America and beyond.
The new state-of-the-art facility will enable the company to increase production ten-fold and meet the growing demand for its patented embedding process. The process applies a light mist of gold particles to a substantial number of materials, including textiles, hard surfaces, and even down insulation. The solution leverages the natural antibacterial properties of gold particles to create a permanent treatment that fights odours, accelerates evaporation, and protects against UVA and UVB radiation.
“As brands increasingly look for sustainable, high-performance solutions, we are scaling up production to meet growing demand,” said Andrew Peterson, Fuze Biotech’s Chief Technology Officer. “Our new facility is state of the art and will help us better serve our expanding roster of sustainability-focused partner brands in North America and abroad.”
Fuze Biotech’s products are extensively used in a range of markets, including bedding, footwear, apparel, hospitality, and more, to keep fabrics and surfaces free from odour and disease-causing mould, bacteria, and pathogens. With consumers becoming increasingly aware of the environmental impact of their purchasing decisions, the demand for sustainable, high-performance solutions has been rising in recent years.
The move to the larger facility in Salt Lake City, Utah, is seen as a positive step forward for the company, as it will enable Fuze Biotech to increase production and better meet the needs of its growing customer base. The company’s commitment to sustainability and innovation has made it a leader in its field, and the relocation is expected to facilitate further growth and expansion.
Fuze Biotech’s gold-powered antibacterial solution has proven to be effective in a variety of markets, and the company has been experiencing a surge in demand from various industries. The company’s products provide an effective solution to the growing concern of the environmental impact of purchasing decisions.
In conclusion, the relocation of Fuze Biotech’s headquarters to a larger facility in Salt Lake City, Utah, is a significant development for the company. With the increased production capacity, Fuze Biotech will be able to meet the growing demand for its sustainable, high-performance solutions and continue to lead the way in the industry. The company’s commitment to sustainability and innovation has made it a leader in its field, and the relocation is expected to facilitate further growth and expansion for Fuze Biotech.